WisdoMont Asset Management is an investment Firm.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
WisdoMont Asset Management is a Shengshan Assets is an excellent venture capital and private equity fund management company in China. Shengshan Assets closely monitors investment opportunities in medical health and smart big data under the trend of consumption upgrading.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2016 | Tenbent Insurance | Seed Round | 1.5M |
2/2016 | Nanobubble | Angel Round | 456.1k |
12/2016 | Tenbent Insurance | Series A | 1.5M |
5/2017 | Hongfund Financial | Angel Round | 0 |
12/2018 | Cryofocus Biotech | Series A | 2.9M |
8/2018 | BANGBANG ROBOT | Series A | - |
7/2020 | OBiO Technology | Series C | 28.5M |
7/2015 | WEFANS | Series A | 0 |
5/2017 | Yuan Qu | Series B | 2.9M |
10/2016 | LinkLab | Series B | 3M |
6/2018 | Weihansi Shengwu | Angel Round | 0 |
12/2016 | Xsleep | Angel Round | 431.1k |
3/2016 | Ruiquan Caring | Angel Round | - |
5/2018 | HeRui BioMed | Series A | 1.6M |
8/2015 | Gu Xiaofan | Angel Round | 0 |
3/2019 | Gaochun Pharmaceutical | Corporate Round | - |
12/2019 | Elpiscience Biopharmaceuticals | Series B | 0 |
1/2016 | LinkLab | Series A | 1.5M |
9/2015 | C-doctor | Angel Round | 1.6M |
6/2018 | INGEEK | Angel Round | 0 |
7/2020 | OBiO Technology | Series C | 0 |
12/2019 | Elpiscience Biopharmaceuticals | Series B | 0 |
3/2019 | Gaochun Pharmaceutical | Corporate Round | - |
12/2018 | Cryofocus Biotech | Series A | 0 |
8/2018 | BANGBANG ROBOT | Series A | - |
6/2018 | Weihansi Shengwu | Angel Round | 0 |
6/2018 | INGEEK | Angel Round | 0 |
5/2018 | HeRui BioMed | Series A | 0 |
5/2017 | Hongfund Financial | Angel Round | 0 |
5/2017 | Yuan Qu | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|